Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope delivers measurable results: reclaim 3 out of every 4 wasted lab kits, 98% site adoption on sponsor-contracted trials, and up to 98% fewer lab queries. By unifying and tech-enabling every step of the biospecimen lifecycle—from supply logistics and sample collection through processing, storage, shipment, and data exchange with core clinical systems like EDCs and lab databases—Slope eliminates the inefficiencies that slow trials and inflate costs. The platform serves research sites, sponsors, and CROs with solutions ranging from base inventory management for sites, to enterprise inventory management and end-to-end biospecimen lifecycle management for all stakeholders. Learn more at slopeclinical.com.
| Website | https://www.slopeclinical.com/ |
| Revenue | $5.7 million |
| Employees | 48 (33 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research |
| Keywords | Biospecimen Management, Clinical Trial Software, Clinical Trial Technology, Lifecycle Management Software, Data Management Software, Clinical Trial Management, Pharmaceutical Software, Healthcare It, Clinical Trial Supply Chain, Life Sciences Software, Precision Medicine Technology, Healthcare Technology Solutions, Clinical Research Technology, Drug Development Technology |
| Competitors | AlayaCare, HHAeXchange, Brightree, Homecare Homebase, Parachute Health, CareCentric, NueHealth LLC, CuraScript SD, Kinnser Software, HealthFusion Inc. +43 more (view full list) |
Looking for a particular Slope employee's phone or email?
The Slope annual revenue was $5.7 million in 2026.
Rust Felix is the CEO of Slope.
33 people are employed at Slope.
Slope is based in Richmond, Virginia.